Brevipil Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Brivaracetam (10mg/ml)
Overview Brevipil Injection
Epileptic seizures are managed with the anticonvulsant Brevipil Injection. Suitable for adults, it can be a monotherapy or adjunctive treatment in adults and children. Consistent use is crucial for sustained seizure control. Brevipil Injection works by reducing abnormal brain electrical activity. Administer with or without food, but maintain consistent daily timing for optimal efficacy. Dosage is individualized based on patient response and condition; your physician will determine the appropriate regimen. Generally prescribed long-term, continued use as directed is essential, even during symptom remission. Discontinuing or missing doses may exacerbate seizures; gradual discontinuation over several months is recommended. Switching brands requires medical consultation. Maintain an adequate supply. While serious adverse events are rare, common side effects include somnolence, anorexia, abdominal discomfort, and diarrhea. Aggression, behavioral changes, depression, insomnia, vertigo, balance issues, rash, and further gastrointestinal upset may also occur. Side effects are often more pronounced initially, generally diminishing with continued use. Though many resolve spontaneously, some require medical attention. Report any symptoms to your doctor; management strategies may be available. Suicidal ideation has been reported in a small subset of patients; consult your physician immediately if mood deteriorates. Prior to commencing treatment, inform your physician of any pre-existing kidney disease, depressive symptoms, suicidal thoughts, pregnancy, or pregnancy plans. Breastfeeding is contraindicated. Alcohol consumption may increase seizure risk and worsen drowsiness and dizziness; avoid alcohol during treatment. Impaired alertness from drowsiness or dizziness may impact driving and operating machinery. Regular kidney function monitoring may be necessary during treatment.
Primary Ingredients of Brevipil Injection
No text provided to rephrase.
Uses of Brevipil Injection
Convulsive disorders
Major Benefits of Brevipil Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Brevipil Injection:
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brevipil Injection:
This medication will be administered by your physician or their nursing staff; self-medication is strongly discouraged.
How Brevipil Injection works:
Brevipil Injection, an anticonvulsant, acts by binding to particular receptors (SV2A) located on neuronal membranes. This binding action diminishes excessive neuronal firing in the brain, thereby inhibiting the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while using Brevipil Injection.
PregnancyCONSULT YOUR DOCTOR
Use of Brevipil Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Brevipil Injection use while breastfeeding is lacking. Seek your physician's advice.
DrivingUNSAFE
Administering Brevipil Injection might reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Brevipil Injection poses no safety concerns for patients with kidney impairment; dosage modification is unnecessary. However, Brivaracetam should be avoided in end-stage renal disease due to the absence of supporting clinical trial data.
LiverCAUTION
Brevipil Injection requires careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Brevipil Injection :
NA
Facts to Know About Brevipil Injection
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Behavioral Class | AED: A protein ligand bound to synaptic vesicle 2 |







